Research Articles | Page 11 | Aplastic Anemia and MDS International Foundation

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journalsort ascending Bone Marrow Disease
Effect of erythropoiesis-stimulating agent policy decisions on off-label use in myelodysplastic syndromes Nov 2014 Medicare Medicaid Res Rev myelodysplastic syndromes (MDS)
Primary Myelodysplastic Syndromes: The Mayo Clinic Experience With 1000 Patients Nov 2015 Mayo Clin Proc myelodysplastic syndromes (MDS)
Polymorphisms of Interlukin-1β rs16944 confer susceptibility to myelodysplastic syndromes Nov 2016 Life Sci. myelodysplastic syndromes (MDS)
SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias Feb 2013 Leukemia myelodysplastic syndromes (MDS)
Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group Feb 2012 Leukemia myelodysplastic syndromes (MDS)
Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes May 2014 Leukemia myelodysplastic syndromes (MDS)
Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs. de novo myelodysplastic syndromes: A report on behalf of the MDS clinical research consortium Jan 2017 Leukemia myelodysplastic syndromes (MDS)
The clinical relevance of minor paroxysmal nocturnal hemoglobinuria clones in refractory cytopenia of childhood - a prospective study by EWOG-MDS. Jun 2013 Leukemia paroxysmal nocturnal hemoglobinuria (PNH)
Risk of acute leukemia and myelodysplastic syndromes in patients with monoclonal gammopathy of undetermined significance (MGUS): a population-based study of 17 315 patients Feb 2013 Leukemia myelodysplastic syndromes (MDS)
Long-term outcome of anemic lower-risk myelodysplastic syndromes without 5q deletion refractory to or relapsing after erythropoiesis-stimulating agents Jan 2013 Leukemia myelodysplastic syndromes (MDS)